Cipla Calls Achaogen Claims Over Lost Ch. 11 Sales 'Weak'
Indian drugmaker Cipla Ltd. Wednesday asked a Delaware bankruptcy judge to trim back a suit alleging it cost bankrupt biopharmaceutical company Achaogen Inc.'s $10 million by frustrating attempts to sell the...To view the full article, register now.
Already a subscriber? Click here to view full article